Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Basware Announces Major Global Expansion Drive as Bookings Grow 52% in 2023




CHARLOTTE, NC and LONDON, Feb. 20, 2024 /PRNewswire/ — Basware, a global leader in AP automation and invoice processing, has announced major global expansion plans as Bookings rose 52 per cent and Recurring Revenue Growth accelerated year-over-year (YoY) in 2023.   

In 2023, Basware acquired Glantus alongside expanding its footprint globally, including markets such as APAC and Southern Europe. Basware has ambitious plans to continue its expansion across the US, Europe and APAC with further investment in customer growth, AI innovation, compliance and fraud prevention expected this year. 

Last year, the company made several key hires including Jason Kurtz as CEO to lead the company’s growth strategy. Basware also welcomed Steve Canning as Chief Revenue Officer and Mark Johnston as Chief Customer Success Officer to drive growth and value for customers throughout the sales and customer cycle. 

Over 2023, following a rebrand and focus on AP (accounts payable) automation, Basware expanded with more than 100 high-profile brands including DHL Express and Alstom, while adding to its global portfolio of 900+ AP customers. It maintained a customer retention rate of 97.4 per cent, for brands that saw value to remain a Basware customer. In 2023, Basware handled over 220 million invoices and $900bn in invoice spend through its platform. 

Basware continued to deliver innovative product solutions in 2023, including SmartPDF with AI Instant Learning that trains AI to recognize exception invoices, an AP Team Performance Discovery dashboard to better manage AP workload, and generative AI customer service tool AskMary.

For almost 40 years, Basware’s AI-enabled AP automation and invoice processing platform has empowered Chief Financial Officers and finance teams at enterprise organisations such as HP and Mercedes-Benz to automatically handle invoices, greatly reducing processing time while boosting accuracy and compliance. With increasing compliance demands for financial teams, Basware helps customers keep up with regulatory mandates and e-invoicing requirements in specific markets around the world.  

In 2023, Basware was recognized as a Gartner Peer Insights™ Customers’ Choice for Procure-to-Pay Suites based on customer reviews. 

Jason Kurtz, CEO at Basware, said:  
“Our commitment to supporting the office of the CFO continues to be a driving force behind Basware’s expansion. Last year, we had one of the most successful financial years in Basware’s 40-year history, and what’s most satisfying about our accomplishments is the positive feedback we’ve received from our customers. Whether it’s Gartner’s Peer Insights or the direct comments we receive about our enhanced customer experience, we are thrilled that the changes we’ve made are positively impacting our customers and we know that the best is yet to come.” 

“Basware’s focus for 2024 centers on supporting enterprise businesses to elevate their finance processes to best practice levels and create value by meeting the ever-changing regulatory needs of financial teams. With our partner first strategy, we are fully aligned to showcase the quantifiable business value of Basware’s solutions, and our strategy continues in enabling all of our customers to be 100 per cent touchless in their AP departments.” 

To drive further growth, Basware has developed a partner first strategy, bolstered by the appointment of Kevin Farrell in 2023 as SVP, Business Development and Alliances. Its strategy will drive innovation for finance teams at enterprises through Basware’s collaboration with professional services firms, financial consultancies and value-added resellers. To enable this strategy, Basware is undertaking a modernization of its knowledge management and e-learning tools to ensure integrated knowledge flows across its organisation and partner ecosystem.  

Services to prevent fraud and ensure compliance are another core pillar of Basware’s growth plans in 2024. It acquired Glantus in October 2023 and expanded its AI-driven overpayment and fraud detection capabilities to alleviate the pressures for over 70 per cent of businesses subject to invoice or payment fraud each year. 

Basware became a privately-held corporation in 2022 in a go-private transaction led by software private equity firm Accel-KKR.  

Dean Jacobson, Chairman of the Board at Basware, and Managing Director at Accel-KKR, commented:  
“The finance function is central to every business, and continues to be more complex as businesses grow. Technology is vital in providing CFOs and their finance teams with the scale, speed and accuracy required to meet business demands. Basware is well on its way in fulfilling a mission to be indispensable to the office of the CFO, and the consortium of investors led by Accel-KKR is committed to backing the company to deliver on that mission.”  

About Basware 
Basware is how finance leaders in global enterprises can finally automate their complex, labor-intensive invoice processes and stay compliant with regulatory change. Our AP automation and invoicing platform helps you achieve a new level of efficiency – in a matter of months – while reducing errors and risks. We bring a unique combination of true automation, complete coverage, and deeper expertise to make it all just happen for our customers. That’s why the world’s most efficient AP departments at thousands of companies rely on Basware to handle over 220 million invoices per year. Basware. Now it all just happens.™ 

Photo –
Photo –

Jason Kurtz, CEO, Basware


Cision View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading